Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2
Published September 2, 2026 · Recall initiated: August 6, 2026
Summary
FDA records drug Class II recall D-0803-2026, published September 2, 2026 and initiated August 6, 2026. Recalling firm: Mallinckrodt Hospital Products Inc.; Status: Ongoing; Reported quantity: 12367 vials; Lot: Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter: glass and stopper piece
What to do
Voluntary: Firm initiated · Letter
Get an email if ACTHAR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ACTHAR
- Manufacturer
- Mallinckrodt Hospital Products Inc.
- Distributor
- USA Nationwide
- UPC
- 0363004871213
- Lot
- Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAZicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton,September 2, 2026
- FDAPaxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: ApotexSeptember 2, 2026
- FDAClobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,September 2, 2026
- FDATyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by FreseniusSeptember 2, 2026
- FDALevothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: AccordSeptember 2, 2026
- FDAActhar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial,February 28, 2024
Questions about this recall
Was Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2 recalled?
Yes. FDA published recall D-0803-2026 on September 2, 2026. Reported hazard: Presence of particulate matter: glass and stopper piece
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ACTHAR. UPC: 0363004871213.